...
首页> 外文期刊>Vaccine >Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine
【24h】

Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine

机译:在烟草和拟南芥中为基于二价植物的疫苗生产重组HIV-1 / HBV病毒样颗粒

获取原文
获取原文并翻译 | 示例
           

摘要

Human immunodeficiency virus (HIV-1) and hepatitis B virus (HBV) spread via similar transmission pathways, and infection by HBV occurs in up to 32% of HIV-1 cases. Here, we describe the successful expression of novel recombinant HIV-1/HBV virus-like particles (VLPs) in Nicotiana tabacum and Arabidopsis thaliana. The production levels and quality of the recombinant VLPs were comparable in the two plants, showing that parameters intrinsic to the recombinant proteins determined their assembly into VLPs. These heterologous VLPs can be used in a bivalent anti-HIV-1/-HBV vaccine, administrated via ingestion of transgenic plants.
机译:人类免疫缺陷病毒(HIV-1)和乙型肝炎病毒(HBV)通过相似的传播途径传播,在多达32%的HIV-1病例中发生了HBV感染。在这里,我们描述了在烟草和拟南芥中成功表达新型重组HIV-1 / HBV病毒样颗粒(VLP)。两种植物中重组VLP的生产水平和质量相当,表明重组蛋白固有的参数决定了它们组装成VLP的能力。这些异源VLP可用于二价抗HIV-1 / -HBV疫苗,通过摄入转基因植物来施用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号